Come up with a name for your new list and we'll add to it:
ViaCyte raised a round of funding on August 25, 2014. Investors include
Johnson & Johnson Innovation.
ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a novel therapy for the treatment of diabetes. The Company's lead product is b…